Background illustration for clinical trials search

Multiple Myeloma Clinical Trials

Browse 1,243 multiple myeloma clinical trials enrolling across the United States and Canada. Search by city or state to find one near you.

Filter
1

Mosaic Trial for Stem Cell Transplant Recipients

for
Hematologic Malignancy, Stem Cell Transplant,
Location: Nutley NJ, Washington D.C. DC, Chicago IL
Sponsor: Northwestern University

Sex: All

Age: 18+

Code: NCT06960993

Recruiting

Measurable Residual Disease-Guided Post-Transplant Elranatamab Maintenance

for
Multiple Myeloma
Location: St Louis MO
Sponsor: Washington University School of Medicine

Sex: All

Age: 18+

Code: NCT06483100

Phase2, Recruiting

IDP-023 as a Single Agent and in Combination With Antibody Therapies in Patients With Advanced Hematologic Cancers

for
NHL, Multiple Myeloma, Blood Cancer,
Location: Providence RI, Fairfax VA, Winston-Salem NC,
Sponsor: Indapta Therapeutics, INC.

Sex: All

Age: 18+

Code: NCT06119685

Phase1, Phase2, Recruiting

A Study to Evaluate Mezigdomide, Bortezomib and Dexamethasone (MEZIVd) Versus Pomalidomide, Bortezomib and Dexamethasone (PVd) in Participants With Relapsed or Refractory Multiple Myeloma (RRMM)

for
Relapsed or Refractory Multiple Myeloma
Location: Boston MA, Shirley NY, Farmington CT, Lake Success NY,
Sponsor: Celgene

Sex: All

Age: 18+

Code: NCT05519085

Phase3, Recruiting

MagnetisMM-32: A Study to Learn About the Study Medicine Called Elranatamab in People With Multiple Myeloma (MM) That Has Come Back After Taking Other Treatments (Including Prior Treatment With an Anti-CD38 Antibody and Lenalidomide)

for
Multiple Myeloma
Location: Moncton, Boston MA, Providence RI, Lake Success NY,
Sponsor: Pfizer

Sex: All

Age: 18+

Code: NCT06152575

Phase3, Recruiting

Interested in new trials?

Get alerts for new trials in your area by subscribing now

Subscriber Image

Study of Belantamab Mafodotin With Carfilzomib, Pomalidomide, and Dexamethasone in Relapsed Multiple Myeloma

for
Multiple Myeloma, Relapse Multiple Myeloma
Location: Chicago IL
Sponsor: University of Chicago

Sex: All

Age: 18+

Code: NCT05789303

Phase2, Recruiting

Minimal Residual Disease Response-adapted Deferral of Transplant in Dysproteinemia (MILESTONE)

for
Multiple Myeloma, Amyloidosis
Location: Birmingham AL
Sponsor: University of Alabama at Birmingham

Sex: All

Age: 18+

Code: NCT04991103

Phase2, Recruiting

Pre-transplant Purging and Post-transplant MRD-guided Maintenance Therapy With Elranatamab in Patients With High-risk Multiple Myeloma

for
Multiple Myeloma,
Location: Houston TX
Sponsor: M.D. Anderson Cancer Center

Sex: All

Age: 18 - 70+

Code: NCT06207799

Phase2, Recruiting

Two Biologically and Clinically Distinct Entities: Progressive Versus Stable Multiple Myeloma (MM) Precursor Conditions

for
Multiple Myeloma, Smoldering Multiple Myeloma,
Location: Miami FL
Sponsor: University of Miami

Sex: All

Age: 18+

Code: NCT05361694

Recruiting

TAPUR: Testing the Use of Food and Drug Administration (FDA) Approved Drugs That Target a Specific Abnormality in a Tumor Gene in People With Advanced Stage Cancer

for
Lymphoma, Non-Hodgkin, Multiple Myeloma, Advanced Solid Tumors
Location: Augusta ME, Brewer ME, Rockport ME, Belfast ME,
Sponsor: American Society of Clinical Oncology

Sex: All

Age: 12+

Code: NCT02693535

Phase2, Recruiting

Vaccine Responses in Patient With Multiple Myeloma and Non-Hodgkin Lymphoma After CAR-T Treatment

for
Chronic Lymphocytic Leukemia, Diffuse Large B-Cell Lymphoma,
Location: Portland OR
Sponsor: OHSU Knight Cancer Institute

Sex: All

Age: 18+

Code: NCT06784167

Recruiting

A Study of Combination of Selinexor, Pomalidomide, and Dexamethasone (SPd) Versus Elotuzumab, Pomalidomide, and Dexamethasone (EloPd) in Subject With Previously Treated Multiple Myeloma

for
Multiple Myeloma
Location: West Reading PA, Bethesda MD, Delray Beach FL,
Sponsor: Stichting European Myeloma Network

Sex: All

Age: 18+

Code: NCT05028348

Phase3, Recruiting

Screening for AL Amyloidosis in Smoldering Multiple Myeloma

for
Smoldering Multiple Myeloma
Location: Boston MA, New York NY, Richmond VA, Durham NC,
Sponsor: Tufts Medical Center

Sex: All

Age: 40+

Code: NCT06365060

Recruiting

MGUS, SMM, and MM Patient Experience With Coronavirus 19 (COVID-19) Survey

for
Multiple Myeloma, Smoldering Multiple Myeloma,
Location: Lehi UT
Sponsor: HealthTree Foundation

Sex: All

Age: 18+

Code: NCT04727294

Recruiting

Study of IgPro20 to Prevent Infection in People With Multiple Myeloma and Hypogammaglobulinemia

for
Multiple Myeloma, Hypogammaglobulinemia,
Location: Commack NY, Uniondale NY, Harrison NY, New York NY,
Sponsor: Memorial Sloan Kettering Cancer Center

Sex: All

Age: 18+

Code: NCT06976476

Phase2, Recruiting

Tacrolimus and MMF as Post Grafting Immunosuppression After Conditioning With Flu TBI for HLA Matched Family Donor

for
Multiple Myeloma, Lymphoma, Acute Myelogenous Leukemia,
Location: Denver CO
Sponsor: Colorado Blood Cancer Institute

Sex: All

Age: 50 - 70

Code: NCT00304720

Phase2, Recruiting

Neurologic Stem Cell Treatment Study

for
Neurologic Disorders, Nervous System Diseases,
Location: Westport CT, Coral Springs FL
Sponsor: MD Stem Cells

Sex: All

Age: 18+

Code: NCT02795052

Recruiting

Response to Emerging Antimicrobial Resistance With Containment Microbiota Therapy (REACT)

for
Multi-Drug Resistant Organism Colonization
Location: Philadelphia PA, Decatur GA, Atlanta GA, Hinsdale IL
Sponsor: Emory University

Sex: All

Age: 18+

Code: NCT06321536

Phase2, Recruiting

Further MT for Antibiotic-Resistant Bacterial Colonization

for
Intestinal Multi-drug Resistant Organism Colonization
Location: Johns Creek GA, Atlanta GA
Sponsor: Emory University

Sex: All

Age: 18+

Code: NCT05835206

Phase2, Recruiting

Fecal Transplant for MDRO Decolonization

for
Multi-antibiotic Resistance
Location: Vancouver
Sponsor: University of British Columbia

Sex: All

Age: 18+

Code: NCT04181112

Recruiting